Chi Hoon Park - Search Results

Year	Number of Results
2005	8
2008	1
2009	1
2010	3
2011	2
2012	2
2013	2
2014	4
2015	5
2016	7
2017	7
2018	6
2019	1
2020	4
2021	7
2022	3
2023	9
2024	3

1

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line.

Kang CH, Kim Y, Lee HK, Lee SM, Jeong HG, Choi SU, Park CH. Kang CH, et al. Among authors: park ch. Int J Mol Sci. 2020 Dec 1;21(23):9163. doi: 10.3390/ijms21239163. Int J Mol Sci. 2020. PMID: 33271901 Free PMC article.

2

Nanocrack-regulated self-humidifying membranes.

Park CH, Lee SY, Hwang DS, Shin DW, Cho DH, Lee KH, Kim TW, Kim TW, Lee M, Kim DS, Doherty CM, Thornton AW, Hill AJ, Guiver MD, Lee YM. Park CH, et al. Nature. 2016 Apr 28;532(7600):480-3. doi: 10.1038/nature17634. Nature. 2016. PMID: 27121841

3

Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion.

Lee DY, Kim Y, Park JS, Choi JU, Jeong HG, Park CH. Lee DY, et al. Among authors: park ch. Anticancer Res. 2023 Sep;43(9):3897-3904. doi: 10.21873/anticanres.16577. Anticancer Res. 2023. PMID: 37648291

4

Optimized conditions for gene transduction into primary immune cells using viral vectors.

Kim Y, Lee DY, Choi JU, Park JS, Lee SM, Kang CH, Park CH. Kim Y, et al. Among authors: park ch. Sci Rep. 2023 Jul 31;13(1):12365. doi: 10.1038/s41598-023-39597-2. Sci Rep. 2023. PMID: 37524755 Free PMC article.

5

Making Potent CAR T Cells Using Genetic Engineering and Synergistic Agents.

Park CH. Park CH. Cancers (Basel). 2021 Jun 29;13(13):3236. doi: 10.3390/cancers13133236. Cancers (Basel). 2021. PMID: 34209505 Free PMC article. Review.

6

Polo-box domain: a versatile mediator of polo-like kinase function.

Park JE, Soung NK, Johmura Y, Kang YH, Liao C, Lee KH, Park CH, Nicklaus MC, Lee KS. Park JE, et al. Among authors: park ch. Cell Mol Life Sci. 2010 Jun;67(12):1957-70. doi: 10.1007/s00018-010-0279-9. Epub 2010 Feb 11. Cell Mol Life Sci. 2010. PMID: 20148280 Free PMC article. Review.

7

Copper-Mediated Three-Component Reaction for the Synthesis of N-Acylsulfonamide on DNA.

Eom S, Kwon T, Lee DY, Park CH, Kim HJ. Eom S, et al. Among authors: park ch. Org Lett. 2022 Jul 15;24(27):4881-4885. doi: 10.1021/acs.orglett.2c01675. Epub 2022 Jul 1. Org Lett. 2022. PMID: 35775977

8

Discovery of BET specific bromodomain inhibitors with a novel scaffold.

Pandit N, Yoo M, Hyun Park T, Kim J, Mi Kim S, Myung Lee K, Kim Y, Min Bong S, Il Lee B, Jung KY, Hoon Park C. Pandit N, et al. Among authors: hoon park c. Bioorg Med Chem. 2022 Oct 15;72:116967. doi: 10.1016/j.bmc.2022.116967. Epub 2022 Aug 23. Bioorg Med Chem. 2022. PMID: 36099719

9

Biodegradation Studies of Polyhydroxybutyrate and Polyhydroxybutyrate-co-Polyhydroxyvalerate Films in Soil.

Kim J, Gupta NS, Bezek LB, Linn J, Bejagam KK, Banerjee S, Dumont JH, Nam SY, Kang HW, Park CH, Pilania G, Iverson CN, Marrone BL, Lee KS. Kim J, et al. Among authors: park ch. Int J Mol Sci. 2023 Apr 21;24(8):7638. doi: 10.3390/ijms24087638. Int J Mol Sci. 2023. PMID: 37108799 Free PMC article.

10

A novel cereblon modulator for targeted protein degradation.

Kim SA, Go A, Jo SH, Park SJ, Jeon YU, Kim JE, Lee HK, Park CH, Lee CO, Park SG, Kim P, Park BC, Cho SY, Kim S, Ha JD, Kim JH, Hwang JY. Kim SA, et al. Among authors: park ch. Eur J Med Chem. 2019 Mar 15;166:65-74. doi: 10.1016/j.ejmech.2019.01.023. Epub 2019 Jan 17. Eur J Med Chem. 2019. PMID: 30684871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year